Oncosil Medical Ltd
ASX:OSL
Oncosil Medical Ltd
ASX:OSL
Price:
0.005 AUD
Market Closed
Updated:
May 2, 2024
Oncosil Medical Ltd
Cash from Operating Activities
|
Oncosil Medical Ltd
Cash from Operating Activities Peer Comparison
Comparables:
ADO
PIQ
CTE
GSS
E
EZZ
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Oncosil Medical Ltd
ASX:OSL
|
Cash from Operating Activities
-AU$10.2m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-16%
|
|
|
Anteotech Ltd
ASX:ADO
|
Cash from Operating Activities
-AU$8.1m
|
CAGR 3-Years
-101%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-17%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Cash from Operating Activities
-AU$5.2m
|
CAGR 3-Years
-160%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Cash from Operating Activities
AU$909.7k
|
CAGR 3-Years
6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
|
Genetic Signatures Ltd
ASX:GSS
|
Cash from Operating Activities
-AU$9.6m
|
CAGR 3-Years
-130%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Cash from Operating Activities
AU$4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Oncosil Medical Ltd's Cash from Operating Activities?
Cash from Operating Activities
-10.2m
AUD
-10.2m
AUD
Based on the financial report for Dec 31, 2023, Oncosil Medical Ltd's Cash from Operating Activities amounts to -10.2m AUD.
What is Oncosil Medical Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-16%
-16%
Over the last year, the Cash from Operating Activities growth was -2%. The average annual Cash from Operating Activities growth rates for Oncosil Medical Ltd have been -15% over the past three years , -6% over the past five years , and -16% over the past ten years .
You don't have any saved screeners yet
